精神分裂症的病前功能、认知功能、症状及转归
Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
作者信息
Addington J, Addington D
机构信息
Department of Psychology, Holy Cross Hospital, Calgary, Alberta, Canada.
出版信息
J Psychiatry Neurosci. 1993 Jan;18(1):18-23.
Abstract
In this study we examined the relationship between premorbid functioning, outcome, cognitive functioning and positive and negative symptoms of schizophrenia. Cognitive functioning and symptoms were examined longitudinally in a sample of 39 subjects with schizophrenia (according to the DSM-III criteria). Subjects were assessed at admission to hospital and six months later during a period of relative remission. Premorbid functioning was significantly associated with negative symptoms but not with positive symptoms at both the acute phase and the remitted phase of the illness. Outcome was also associated with negative symptoms at admission and with both positive and negative symptoms at follow-up. Deficits on cognitive tests of verbal reasoning and concept formation were significantly associated with poor premorbid functioning and outcome.
摘要
在本研究中，我们考察了病前功能、治疗结果、认知功能与精神分裂症的阳性和阴性症状之间的关系。对39名符合《精神疾病诊断与统计手册第三版》（DSM-III）标准的精神分裂症患者样本进行了认知功能和症状的纵向研究。在患者入院时及六个月后处于相对缓解期时进行评估。病前功能在疾病的急性期和缓解期均与阴性症状显著相关，而与阳性症状无关。治疗结果在入院时与阴性症状相关，在随访时与阳性和阴性症状均相关。言语推理和概念形成的认知测试缺陷与不良的病前功能及治疗结果显著相关。
相似文献
1
Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
J Psychiatry Neurosci. 1993 Jan;18(1):18-23.
2
The relationship of premorbid functioning to illness course in schizophrenia and psychotic mood disorders during two years following first hospitalization.
J Nerv Ment Dis. 2006 Oct;194(10):791-5. doi: 10.1097/01.nmd.0000240158.39929.e3.
3
Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.
Psychiatry Res. 2008 Jul 15;160(1):47-54. doi: 10.1016/j.psychres.2007.06.024. Epub 2008 Jun 4.
4
Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
Arch Gen Psychiatry. 2005 Feb;62(2):127-36. doi: 10.1001/archpsyc.62.2.127.
5
[Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Encephale. 2001 Sep-Oct;27(5):405-15.
6
Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
J Affect Disord. 2008 Aug;109(3):286-99. doi: 10.1016/j.jad.2007.12.234. Epub 2008 Mar 4.
7
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
8
Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains.
Acta Psychiatr Scand. 2005 Jul;112(1):30-9. doi: 10.1111/j.1600-0447.2005.00555.x.
9
The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study.
Psychiatry Res. 2013 Oct 30;209(3):353-60. doi: 10.1016/j.psychres.2013.02.014. Epub 2013 Mar 7.
10
Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.
Psychiatry Res. 2005 Jan 30;133(1):45-55. doi: 10.1016/j.psychres.2004.10.001.
引用本文的文献
1
The trace amine-associated receptor 1 agonists - non-dopaminergic antipsychotics or covert modulators of D2 receptors?
J Psychopharmacol. 2024 Jun;38(6):503-506. doi: 10.1177/02698811241249415. Epub 2024 Apr 23.
2
Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.
PLoS One. 2023 Sep 21;18(9):e0288354. doi: 10.1371/journal.pone.0288354. eCollection 2023.
3
Learning without contingencies: A loss of synergy between memory and reward circuits in schizophrenia.
Schizophr Res. 2023 Aug;258:21-35. doi: 10.1016/j.schres.2023.06.004. Epub 2023 Jul 18.
4
Premorbid adjustment amongst outpatients with schizophrenia in a Nigerian psychiatric facility.
S Afr J Psychiatr. 2021 May 28;27:1492. doi: 10.4102/sajpsychiatry.v27i0.1492. eCollection 2021.
5
Negative Symptoms and Functioning in Youth at Risk of Psychosis: A Systematic Review and Meta-analysis.
Harv Rev Psychiatry. 2020 Nov/Dec;28(6):341-355. doi: 10.1097/HRP.0000000000000273.
6
CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study.
Psychopharmacology (Berl). 2020 Dec;237(12):3665-3687. doi: 10.1007/s00213-020-05646-1. Epub 2020 Aug 27.
7
Schizophrenia, Not a Psychotic Disorder: Bleuler Revisited.
Front Psychiatry. 2019 May 10;10:328. doi: 10.3389/fpsyt.2019.00328. eCollection 2019.
8
Cognitive impairment from early to middle adulthood in patients with affective and nonaffective psychotic disorders.
Psychol Med. 2020 Jan;50(1):48-57. doi: 10.1017/S0033291718003938. Epub 2019 Jan 4.
9
Current Status of Cognitive Remediation for Psychiatric Disorders: A Review.
Front Psychiatry. 2018 Oct 1;9:461. doi: 10.3389/fpsyt.2018.00461. eCollection 2018.
10
Vulnerability to psychosocial disability in psychosis.
Epidemiol Psychiatr Sci. 2019 Apr;28(2):140-145. doi: 10.1017/S2045796018000495. Epub 2018 Sep 12.
本文引用的文献
1
Negative v positive schizophrenia. Definition and validation.
Arch Gen Psychiatry. 1982 Jul;39(7):789-94. doi: 10.1001/archpsyc.1982.04290070025006.
2
Information processing and attentional functioning in the developmental course of schizophrenic disorders.
Schizophr Bull. 1984;10(2):160-203. doi: 10.1093/schbul/10.2.160.
3
Negative and positive symptoms in schizophrenia and depression: a followup.
Schizophr Bull. 1984;10(3):371-87. doi: 10.1093/schbul/10.3.371.
4
Localisation of cerebral lesions by psychological testing.
Clin Neurosurg. 1969;16:269-87. doi: 10.1093/neurosurgery/16.cn_suppl_1.269.
5
The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia.
Arch Gen Psychiatry. 1974 Jul;31(1):37-42. doi: 10.1001/archpsyc.1974.01760130021003.
6
Negative symptoms in schizophrenia: their longitudinal course and prognostic importance.
Schizophr Bull. 1985;11(3):427-39. doi: 10.1093/schbul/11.3.427.
7
The positive and negative syndrome scale (PANSS) for schizophrenia.
Schizophr Bull. 1987;13(2):261-76. doi: 10.1093/schbul/13.2.261.
8
A multidimensional approach to the genetics of schizophrenia.
Am J Psychiatry. 1988 Sep;145(9):1077-83. doi: 10.1176/ajp.145.9.1077.
9
The positive/negative symptom distinction in schizophrenia. Validity and etiological relevance.
Schizophr Res. 1988 Sep-Oct;1(5):315-28. doi: 10.1016/0920-9964(88)90045-x.
10
Premorbid sociosexual functioning and long-term outcome in schizophrenia.
Am J Psychiatry. 1989 Feb;146(2):206-11. doi: 10.1176/ajp.146.2.206.
Zotero 插件